Immuno-Oncology
FDA Approves Nivolumab/Ipilimumab for Metastatic CRC Subgroup
BY JASON M. BRODERICK
The Top Five Oncology Nursing News Stories of June 2018
BY JESSICA SKARZYNSKI
A Guide to Nursing Discharge of Patients Receiving CAR T-Cell Therapy
BY KARA YANNOTTI, MMH, RN, ELIZABETH MCCARTHY, MSN, RN, SABRINA KDIRY, BSN, RN, AND LORI DAHNCKE, BSN, RN
ASCO 2018 Highlights: Is Your Immune System Born or Made?
BY MAGGIE A. SMITH, DNP, MSN/ED, RN, OCN
Monitoring Adverse Effects of Immunotherapy
BY BETH FAND INCOLLINGO
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.